Cannabis-Derived drug tested to ease crippling arthritis pain
Symptom relief
Terminated
This study tested whether a new combination drug called IHL-675A could safely reduce pain and improve daily function for people with rheumatoid arthritis. The drug combined two existing medications: cannabidiol (CBD) and hydroxychloroquine (HCQ). The trial compared the combinatio…
Phase: PHASE2 • Sponsor: Incannex Healthcare Ltd • Aim: Symptom relief
Last updated Apr 03, 2026 14:43 UTC